AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

LivQ-box® Parameters in the Diagnosis of Liver Inflammation

Recruitingn/aAges 18 Years - anyAllWuxi Hisky Medical Technology Co Ltd
💬

In plain words

What the trial is, and whether it could suit you

To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with NAFLD according to The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases; * Age over 18 years old, gender not limited; * Not combined with liver diseases (such as viral hepatitis, drug-induced liver injury, autoimmune liver disease); * Perform iLivTouch examination within ± 14 days of liver pathology examination; * No history of excessive alcohol consumption (converted to ethanol:\<140g/week for males,\<70g/week for females);
💊

What it tests

  • Not listed
📍

Where

1 site
Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy